Tailored Supplemental Screening for Breast Cancer: What Now and What Next?

被引:117
作者
Berg, Wendie A. [1 ]
机构
[1] Amer Radiol Serv, Dept Radiol, Lutherville Timonium, MD 21093 USA
关键词
breast cancer screening; breast imaging; breast MRI; breast sonography; gamma imaging; mammography; PET; HIGH FAMILIAL RISK; MUTATION CARRIERS; DENSE BREASTS; GENETIC PREDISPOSITION; DIGITAL MAMMOGRAPHY; COST-EFFECTIVENESS; BRCA2; MUTATION; FOLLOW-UP; WOMEN; ULTRASOUND;
D O I
10.2214/AJR.08.1706
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. This article reviews breast cancer risk assessment and the rationale for current screening guidelines, including when to consider using supplemental screening with MRI or sonography in addition to mammography, and discusses other emerging technologies. Radiologists can help identify women who may benefit from supplemental screening and can help to recommend when and which techniques to perform for this additional screening. CONCLUSION. Mammography remains the mainstay of breast cancer screening. Mammography should be performed as digital imaging when possible in women with dense breasts. In women at high risk, particularly if they also have dense breasts, annual MRI is recommended, although further validation of outcomes is needed. In intermediate-risk women with dense breasts, especially those with other risk factors, and in high-risk women with dense breasts who are unable to tolerate MRI, supplemental sonography screening is an option at facilities with availability of qualified personnel. Developing technologies are not appropriate for screening at this time, although further study is encouraged.
引用
收藏
页码:390 / 399
页数:10
相关论文
共 81 条
[1]  
Abu-Alfa Ali, 2008, J Am Coll Radiol, V5, P45, DOI 10.1016/j.jacr.2007.08.018
[2]  
Adams-Campbell LL, 2007, BREAST J, V13, P332, DOI 10.1111/j.1524-4741.2007.00439.x
[3]  
Aisenberg AC, 1997, CANCER, V79, P1203, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1203::AID-CNCR20>3.0.CO
[4]  
2-2
[5]   Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme [J].
Amir, E ;
Evans, DG ;
Shenton, A ;
Lalloo, F ;
Moran, A ;
Boggis, C ;
Wilson, M ;
Howell, A .
JOURNAL OF MEDICAL GENETICS, 2003, 40 (11) :807-814
[6]  
[Anonymous], 1996, Cost-effectiveness in health and medicine
[7]  
[Anonymous], BREAST CANC RISK ASS
[8]  
[Anonymous], Breast Cancer Facts Figures
[9]   The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions [J].
Antoniou, A. C. ;
Cunningham, A. P. ;
Peto, J. ;
Evans, D. G. ;
Lalloo, F. ;
Narod, S. A. ;
Risch, H. A. ;
Eyfjord, J. E. ;
Hopper, J. L. ;
Southey, M. C. ;
Olsson, H. ;
Johannsson, O. ;
Borg, A. ;
Passini, B. ;
Radice, P. ;
Manoukian, S. ;
Eccles, D. M. ;
Tang, N. ;
Olah, E. ;
Anton-Culver, H. ;
Warner, E. ;
Lubinski, J. ;
Gronwald, J. ;
Gorski, B. ;
Tryggvadottir, L. ;
Syrjakoski, K. ;
Kallioniemi, O-P ;
Eerola, H. ;
Nevanlinna, H. ;
Pharoah, P. D. P. ;
Easton, D. F. .
BRITISH JOURNAL OF CANCER, 2008, 98 (08) :1457-1466
[10]   Mammography before diagnosis among women age 80 years and older with breast cancer [J].
Badgwell, Brian D. ;
Giordano, Sharon H. ;
Duan, Zhigang Z. ;
Fang, Shenying ;
Bedrosian, Isabelle ;
Kuerer, Henry M. ;
Singletary, S. Eva ;
Hunt, Kelly K. ;
Hortobagyi, Gabriel N. ;
Babiera, Gildy .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) :2482-2488